Community-reported Memantine side effects:
paranoia, delusions, aggression 2008-10-20 21:40:31
Add Your Side Effect to the Community Database
Help Community - Describe Your Memantine Side Effect
Have You dealt with a Memantine side effect? Share your experience
Review Memantine Safety Reports submitted to FDA
Total Memantine reports: 209.Memantine FDA safety alerts: No.
Reported deaths: 46 Reported hospitalizations: 112.
Take Memantine Side Effects Survey, Discuss Memantine with others
FDA Reported Memantine Side Effects: fall, condition aggravated, blood creatine phosphokinase increased, aspartate aminotransferase increased, cholelithiasis, agitation, depressed level of consciousness, dehydration, alanine aminotransferase increased, cerebral atrophy, anorexia.
More About Memantine.
If you have questions about Memantine, you can ask a Health Expert or Ask Patient Community about Memantine.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
Showing 1-100 of 209 Next >
Memantine Side Effects Report #5489224-2Physician from UNITED STATES reported MEMANTINE problem on Oct 03, 2007. Male patient, 66 years of age, weighting 171.3 lb, was diagnosed with cognitive disorder, dementia, parkinson's disease and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anxiety, condition aggravated, dyspraxia, hallucination, visual, initial insomnia, middle insomnia, paranoia, parkinson's disease, prostatitis. MEMANTINE dosage: unknown. Patient recovered.
Memantine Side Effects Report #5491265-6
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on Oct 05, 2007. Female patient, 77 years of age, weighting 81.57 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: gastric cancer. MEMANTINE dosage: unknown. During the same period patient was treated with REBAMIPIDE, DOMPERIDONE, VERAPAMIL HYDROCHLORIDE, SENNOSIDE. Patient recovered.
Memantine Side Effects Report #5491271-1
Health Professional from FRANCE reported MEMANTINE problem on Oct 02, 2007. Female patient, 69 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, hepatitis cholestatic, pyelonephritis acute, sepsis. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with OFLOXACIN, TAZOCILINE, CEFTRIAXONE, SKENAN, ACTISEKNAN, ZOCOR, ACUPAN, THERALENE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5491408-4
MEMANTINE problem was reported by a Health Professional from FRANCE on Oct 03, 2007. Female patient, 80 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with ANTIHYPERTENSIVE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5492700-X
Health Professional from ITALY reported MEMANTINE problem on Oct 04, 2007. Female patient, 92 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: hepatitis cholestatic. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DIGOXIN, LISINOPRIL, TIAPRIDE, ALPRAZOLAM, PROMAZINE HYDROCHLORIDE. Patient recovered.
Memantine Side Effects Report #5500275-1
MEMANTINE problem was reported by a Health Professional from JAPAN on Oct 11, 2007. Female patient, 88 years of age, weighting 90.39 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, bile duct stone, biliary tract infection, cholelithiasis, gallbladder disorder, hepatic cyst, hepatic lesion, liver abscess, restlessness. MEMANTINE dosage: unknown. During the same period patient was treated with BROTIZOLAM, AMLODIPINE BESYLATE, VALSARTAN, FELBINAC. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5500276-3
Health Professional from FRANCE reported MEMANTINE problem on Oct 12, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with EQUANIL, CHLORURE POTASSIUM. Patient died on 07/02/2007.
Memantine Side Effects Report #5500353-7
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on Oct 12, 2007. Female patient, 63 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type, disease progression and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, agitation, crying, delirium, hallucination, visual. MEMANTINE dosage: 5 MG QD PO. During the same period patient was treated with EXELON, MIRTAZAPINE, XANAX, RISPERDAL. Patient recovered.
Memantine Side Effects Report #5505165-6
Consumer or non-health professional from UNITED STATES reported MEMANTINE problem on Oct 24, 2007. Female patient, 70 years of age, weighting 170.6 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anoxic encephalopathy, aortic thrombosis, aspiration, blood glucose increased, blood phosphorus increased, bronchopneumonia, cardiac arrest, cardio-respiratory arrest, cerebellar atrophy. MEMANTINE dosage: 28 MG QD;PO. During the same period patient was treated with ARICEPT, CALTRATE, CELEXA, FOLBIC, VATAMINS, PLAQUENIL, VITAMIN E. Patient was hospitalized. Patient died on 07/18/2007.
Memantine Side Effects Report #5505950-0
MEMANTINE problem was reported by a Consumer or non-health professional from JAPAN on Oct 19, 2007. Female patient, 77 years of age, weighting 81.57 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: adenocarcinoma, gastric cancer, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression, red blood cell count decreased, weight decreased, white blood cell count decreased. MEMANTINE dosage: unknown. During the same period patient was treated with REBAMIDIPIDE, DOMPERIDONE, VERAPAMIL HYDROCHLORIDE, SENNOSIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5449459-1
Physician from ARGENTINA reported MEMANTINE problem on Aug 25, 2007. Female patient, 80 years of age, weighting 160.9 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus inadequate control, diabetic foot. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with INSULIN, OLANZAPINE, PAROXETINE, DONEPEZIL, ALPRAZOLAM, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5451099-5
MEMANTINE problem was reported by a Health Professional from GERMANY on Aug 23, 2007. Male patient, 70 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 10 MG BID PO. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5458193-3
Physician from ARGENTINA reported MEMANTINE problem on Aug 25, 2007. Female patient, 80 years of age, weighting 160.9 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: dermatitis bullous, diabetes mellitus inadequate control, diabetic foot, localised infection, malaise, varicose vein. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with INSULIN, OLANZAPINE, PAROXETINE, DONEPEZIL, ALPRAZOLAM, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5458219-7
MEMANTINE problem was reported by a Physician from ARGENTINA on Sept 07, 2007. Male patient, 75 years of age, weighting 140.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anxiety, cardiac arrest, cardiac failure. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with DONEPEZIL, EZOPICLONE. Patient died on 09/05/2007.
Memantine Side Effects Report #5466864-8
Health Professional from FRANCE reported MEMANTINE problem on Aug 13, 2007. Male patient, 85 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood urea increased, cerebral atrophy, dehydration, rhabdomyolysis. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, RISPERDAL. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5468659-8
MEMANTINE problem was reported by a Physician from ARGENTINA on Sept 13, 2007. Female patient, 80 years of age, weighting 160.9 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, dermatitis bullous, diabetes mellitus inadequate control, diabetic foot, localised infection, malaise, microcytosis, red blood cell count decreased. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with INSULIN, OLANZAPINE, PAROXETINE, DONEPEZIL, ALPRAZOLAM, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5468661-6
Health Professional from FRANCE reported MEMANTINE problem on Sept 06, 2007. Male patient, 79 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood sodium increased, dehydration, lung infection, renal failure acute, somnolence. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with VALSARTAN AND HYDROCHLOROTHIAZIDE, ARICEPT, DEROXAT, RISPERDAL. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5468662-8
MEMANTINE problem was reported by a Health Professional from ITALY on Sept 10, 2007. Female patient, 92 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: hepatitis cholestatic. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DIGOXIN, LISINOPRIL, TIAPRIDE, ALPRAZOLAM, PROMAZINE HYDROCHLORIDE. Patient recovered.
Memantine Side Effects Report #5404755-9
Health Professional from JAPAN reported MEMANTINE problem on July 24, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholecystitis, cholelithiasis, heart rate increased. MEMANTINE dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOXYCHOLIC ACID. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5405942-6
MEMANTINE problem was reported by a Physician from UNITED STATES on July 19, 2007. Female patient, 75 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, agitation, bacteria urine, blood pressure decreased, body temperature increased, cardiomegaly, dehydration, hypernatraemia. MEMANTINE dosage: unknown. During the same period patient was treated with LIPITOR, ALLERGRA, EXELON, PRILOSEC, CALCIUM CHLORIDE, CENTRIUM SILVER, ASPIRIN, GLYCOLAX. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5406185-2
Physician from UNITED STATES reported MEMANTINE problem on July 26, 2007. Male patient, 85 years of age, weighting 183.0 lb, was diagnosed with atrophy and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood pressure increased, blood urea increased, bradycardia, dilatation atrial, dizziness, fall, haematocrit decreased, haemoglobin decreased. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DONEPEZIL, WARFARIN, SOTALOL HYDROCHLORIDE, GLYBURIDE AND METFORMIN, ACTOS, SIMVASTATIN, TERAZOSIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5421468-8
MEMANTINE problem was reported by a Physician from UNITED STATES on Aug 07, 2007. Female patient, 75 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, agitation, blood pressure decreased, body temperature increased, cardiomegaly, condition aggravated, dehydration, fall. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with LIPITOR, ALLEGRA, EXELON, PRILOSEC, CALCIUM, CENTRUM SILVER, ASPIRIN, GLYCOLAX. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5423129-8
Health Professional from UNITED KINGDOM reported MEMANTINE problem on June 22, 2007. Male patient, 78 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, fall, unresponsive to stimuli. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, SOTALOL HYDROCHLORIDE, GLICLAZINE, FYBOGEL, SENNA, HYDROXOCOBALAMIN, DONEPEZIL, GALANTAMINE HYDROBROMIDE. Patient was hospitalized. Patient died on 06/30/2007.
Memantine Side Effects Report #5428334-2
MEMANTINE problem was reported by a Health Professional from UNITED KINGDOM on Aug 21, 2007. Male patient, 78 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, fall, loss of consciousness, pain. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, SOTALOL HYDROCHLORIDE, GLICLAZINE, FYBOGEL, SENNA, HYDROXOCOBALAMIN, DONEPEZIL, GALANTAMINE HYDROBROMIDE. Patient was hospitalized. Patient died on 06/30/2007.
Memantine Side Effects Report #5302412-0
Health Professional from GERMANY reported MEMANTINE problem on Apr 02, 2007. Male patient, 88 years of age, weighting 147.5 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arthritis, blood pressure systolic increased, bronchopneumonia, c-reactive protein increased, cough, decreased activity, pyrexia, somnolence. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, TEPRENONE, ASPIRIN, URSODIOL, TERBINAFINE, BETAMETHASONE DIPROPIONATE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5380529-2
MEMANTINE problem was reported by a Consumer or non-health professional from GREECE on June 18, 2007. Female patient, 94 years of age, weighting 110.2 lb, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with SEROQUEL, SALOSPIR, THYROHORMONE. Patient recovered.
Memantine Side Effects Report #5383169-4
Health Professional from IRELAND reported MEMANTINE problem on June 06, 2007. Female patient, 86 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: antineutrophil cytoplasmic antibody positive, dialysis, renal failure, vasculitis. MEMANTINE dosage: unknown. Patient recovered.
Memantine Side Effects Report #5383861-1
MEMANTINE problem was reported by a Physician from UNITED STATES on June 26, 2007. Female patient, 65 years of age, weighting 119.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: balance disorder, ecchymosis, face injury, fall. MEMANTINE dosage: 28 MG QD;PO. During the same period patient was treated with ACETAMINOPHEN, ASPIRIN, ARTHROTEC, TRIAMCINOLONE ACETONIDE, GALANTAMINE HYDROBROMIDE, GLUCOSAMINE CHONDROITIN. Patient recovered.
Memantine Side Effects Report #5385507-5
Health Professional from FRANCE reported MEMANTINE problem on June 26, 2007. Male patient, 61 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, condition aggravated. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with EXELON, FORADIL, MIFLASONE, STABLON, ASPIRIN, PRAVASTATIN. Patient recovered.
Memantine Side Effects Report #5385569-5
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on May 04, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type, fatigue, social avoidant behaviour and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, blood pressure systolic decreased, cardiogenic shock, chest pain, coronary artery disease, coronary artery occlusion, coronary artery stenosis, dyspnoea. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, RITALIN, DILTIAZEM, METOPROLOL SUCCINATE, SIMVASTATIN, GEMFIBROZIL, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5391702-1
Health Professional from GERMANY reported MEMANTINE problem on July 02, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, chest pain, cholecystitis, cholelithiasis, condition aggravated, heart rate increased, pyrexia. MEMANTINE dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOYXCHOLIC ACID, MIDODRINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5393009-5
MEMANTINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2007. Male patient, 62 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cardiac hypertrophy, cerebral atrophy, homicide, poisoning, unresponsive to stimuli. MEMANTINE dosage: 10 MG BID. During the same period patient was treated with DONEPEZIL, CLONAZEPAM, PROPOXYPHENE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE. Patient died.
Memantine Side Effects Report #5394930-4
Health Professional from GERMANY reported MEMANTINE problem on July 09, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type, fatigue, social avoidant behaviour and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, blood creatine phosphokinase increased, cardiogenic shock, chest pain, coronary artery stenosis, dizziness, dyspnoea, ejection fraction decreased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with DILTIAZEM, DONEPEZIL, RITALIN, METOPROLOL EXTENDED, SIMVASTATIN, GEMFIBROZIL, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5403515-2
MEMANTINE problem was reported by a Health Professional from FRANCE on July 16, 2007. Female patient, 86 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete. MEMANTINE dosage: unknown. During the same period patient was treated with GALANTAMINE HYDROBROMIDE. Patient recovered.
Memantine Side Effects Report #5404679-7
Health Professional from GERMANY reported MEMANTINE problem on Nov 14, 2005. Male patient, 78 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood disorder, chronic lymphocytic leukaemia, condition aggravated, fluid retention, hepatocellular damage, splenomegaly. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, TRAZODONE, LOXAPINE, ASPIRIN, RABEPRAZOLE, TEGRETOL, ACETAMINOPHEN. Patient recovered.
Memantine Side Effects Report #5302412-0
MEMANTINE problem was reported by a Health Professional from GERMANY on Apr 02, 2007. Male patient, 88 years of age, weighting 147.5 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arthritis, blood pressure systolic increased, bronchopneumonia, c-reactive protein increased, cough, decreased activity, pyrexia, somnolence. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, TEPRENONE, ASPIRIN, URSODIOL, TERBINAFINE, BETAMETHASONE DIPROPIONATE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5380529-2
Consumer or non-health professional from GREECE reported MEMANTINE problem on June 18, 2007. Female patient, 94 years of age, weighting 110.2 lb, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with SEROQUEL, SALOSPIR, THYROHORMONE. Patient recovered.
Memantine Side Effects Report #5383169-4
MEMANTINE problem was reported by a Health Professional from IRELAND on June 06, 2007. Female patient, 86 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: antineutrophil cytoplasmic antibody positive, dialysis, renal failure, vasculitis. MEMANTINE dosage: unknown. Patient recovered.
Memantine Side Effects Report #5383861-1
Physician from UNITED STATES reported MEMANTINE problem on June 26, 2007. Female patient, 65 years of age, weighting 119.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: balance disorder, ecchymosis, face injury, fall. MEMANTINE dosage: 28 MG QD;PO. During the same period patient was treated with ACETAMINOPHEN, ASPIRIN, ARTHROTEC, TRIAMCINOLONE ACETONIDE, GALANTAMINE HYDROBROMIDE, GLUCOSAMINE CHONDROITIN. Patient recovered.
Memantine Side Effects Report #5385507-5
MEMANTINE problem was reported by a Health Professional from FRANCE on June 26, 2007. Male patient, 61 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, condition aggravated. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with EXELON, FORADIL, MIFLASONE, STABLON, ASPIRIN, PRAVASTATIN. Patient recovered.
Memantine Side Effects Report #5385569-5
Consumer or non-health professional from GERMANY reported MEMANTINE problem on May 04, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type, fatigue, social avoidant behaviour and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, blood pressure systolic decreased, cardiogenic shock, chest pain, coronary artery disease, coronary artery occlusion, coronary artery stenosis, dyspnoea. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, RITALIN, DILTIAZEM, METOPROLOL SUCCINATE, SIMVASTATIN, GEMFIBROZIL, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5391702-1
MEMANTINE problem was reported by a Health Professional from GERMANY on July 02, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, chest pain, cholecystitis, cholelithiasis, condition aggravated, heart rate increased, pyrexia. MEMANTINE dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOYXCHOLIC ACID, MIDODRINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5393009-5
Consumer or non-health professional from UNITED STATES reported MEMANTINE problem on July 06, 2007. Male patient, 62 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cardiac hypertrophy, cerebral atrophy, homicide, poisoning, unresponsive to stimuli. MEMANTINE dosage: 10 MG BID. During the same period patient was treated with DONEPEZIL, CLONAZEPAM, PROPOXYPHENE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE. Patient died.
Memantine Side Effects Report #5394930-4
MEMANTINE problem was reported by a Health Professional from GERMANY on July 09, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type, fatigue, social avoidant behaviour and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, blood creatine phosphokinase increased, cardiogenic shock, chest pain, coronary artery stenosis, dizziness, dyspnoea, ejection fraction decreased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with DILTIAZEM, DONEPEZIL, RITALIN, METOPROLOL EXTENDED, SIMVASTATIN, GEMFIBROZIL, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5403515-2
Health Professional from FRANCE reported MEMANTINE problem on July 16, 2007. Female patient, 86 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete. MEMANTINE dosage: unknown. During the same period patient was treated with GALANTAMINE HYDROBROMIDE. Patient recovered.
Memantine Side Effects Report #5404679-7
MEMANTINE problem was reported by a Health Professional from GERMANY on Nov 14, 2005. Male patient, 78 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood disorder, chronic lymphocytic leukaemia, condition aggravated, fluid retention, hepatocellular damage, splenomegaly. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, TRAZODONE, LOXAPINE, ASPIRIN, RABEPRAZOLE, TEGRETOL, ACETAMINOPHEN. Patient recovered.
Memantine Side Effects Report #5759053-0
Consumer or non-health professional from FRANCE reported MEMANTINE problem on May 16, 2008. Female patient, 86 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal, epilepsy, gait disturbance, somnolence, tremor. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with ATHYMIL, RISPERDAL, IMOVANE, KARDEGIC. Patient recovered.
Memantine Side Effects Report #5759180-8
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on May 13, 2008. Male patient, 81 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with PREVISCAN, INEXIUM, PRAVASTATIN, COAPROVEL, DIGOXIN, ALLOPURINOL. Patient recovered.
Memantine Side Effects Report #5762092-7
Health Professional from GERMANY reported MEMANTINE problem on May 16, 2008. Female patient, 86 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal, epilepsy, gait disturbance, somnolence, tremor. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with ATHYMIL, RISPERDAL, IMOVANE, KARDEGIC. Patient recovered.
Memantine Side Effects Report #5762105-2
MEMANTINE problem was reported by a Health Professional from GERMANY on May 22, 2008. Female patient, 82 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: self-injurious ideation, suicidal ideation. MEMANTINE dosage: 5 MG BID; PO. During the same period patient was treated with MIRTAZAPINE, DIAZEPAM. Patient recovered.
Memantine Side Effects Report #5768274-2
Consumer or non-health professional from FRANCE reported MEMANTINE problem on May 26, 2008. Male patient, 82 years of age, weighting 165.3 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: axillary vein thrombosis, jugular vein thrombosis, lymphadenopathy, subclavian vein thrombosis. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with EXELON, JOSIR, TEMERIT, ALLOPURINOL. Patient recovered.
Memantine Side Effects Report #5768289-4
MEMANTINE problem was reported by a Consumer or non-health professional from FRANCE on May 26, 2008. Female patient, 77 years of age, weighting 97.00 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, arteriosclerosis, myocardial infarction, stress, ventricular hypokinesia. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, XANAX, IMOVANE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5768807-6
Health Professional from GERMANY reported MEMANTINE problem on May 27, 2008. Female patient, 94 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: hepatic failure, hepatomegaly, jaundice. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with KARDEGIC, ZESTORETIC. Patient was hospitalized. Patient died on 11/10/2007.
Memantine Side Effects Report #5768868-4
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on May 26, 2008. Female patient, 81 years of age, weighting 99.21 lb, was diagnosed with cognitive disorder and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anxiety, balance disorder, condition aggravated, disorientation, major depression. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with IRBESARTAN, STABLON, LEVOTHYROXINE, KEPPRA. Patient recovered.
Memantine Side Effects Report #5775559-2
Consumer or non-health professional from FRANCE reported MEMANTINE problem on May 28, 2008. Female patient, 85 years of age, weighting 99.21 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, electrocardiogram qt prolonged, gastrointestinal haemorrhage, hypokalaemia, torsade de pointes. MEMANTINE dosage: 10 MG BID; PO. During the same period patient was treated with PROPRANOLOL, NITRIDERM TTS, ANAFRANIL, COZAAR, IMOVANE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5775560-9
MEMANTINE problem was reported by a Consumer or non-health professional from FRANCE on May 29, 2008. Female patient, 89 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bradycardia, bundle branch block left, electrocardiogram t wave inversion, hypertension, left ventricular hypertrophy, loss of consciousness, syncope. MEMANTINE dosage: 10 MG, BID; PO. During the same period patient was treated with TRANSIPEG. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5775561-0
Consumer or non-health professional from FRANCE reported MEMANTINE problem on May 29, 2008. Male patient, 81 years of age, was diagnosed with dementia alzheimer's type, prostatic adenoma and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree, bradycardia, malaise, syncope. MEMANTINE dosage: unknown. During the same period patient was treated with TAMSULOSIN, CLOPIDOGREL. Patient recovered.
Memantine Side Effects Report #5776065-1
MEMANTINE problem was reported by a Consumer or non-health professional from TURKEY on June 02, 2008. Female patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: ischaemic stroke. MEMANTINE dosage: 20 MG QD PO. Patient died on 05/25/2008.
Memantine Side Effects Report #5776066-3
Consumer or non-health professional from FRANCE reported MEMANTINE problem on May 29, 2008. Female patient, 89 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic decreased, blood pressure systolic increased, bradycardia, bundle branch block left, electrocardiogram t wave inversion, left ventricular hypertrophy, loss of consciousness. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with TRANSIPEG. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5776252-2
MEMANTINE problem was reported by a Health Professional from FRANCE on May 29, 2008. Female patient, 85 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, bundle branch block right, condition aggravated, hypothyroidism, left ventricular hypertrophy, oedema peripheral, rales, renal failure chronic, sinus bradycardia. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, PRAVASTATIN, FUROSEMIDE, LEVOTHYROXINE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5779770-6
Consumer or non-health professional from UNITED KINGDOM reported MEMANTINE problem on June 02, 2008. Male patient, 75 years of age, was diagnosed with dementia, parkinson's disease and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood urea increased, feeling hot, flushing, paraesthesia, sinus bradycardia, spinal osteoarthritis. MEMANTINE dosage: unknown. During the same period patient was treated with SINEMET, ATENOLOL, LISINOPRIL, SOLPADENE, STALEVO. Patient recovered.
Memantine Side Effects Report #5782003-8
MEMANTINE problem was reported by a Pharmacist from GERMANY on June 13, 2008. Female patient, child 4 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, depressed level of consciousness, disturbance in attention, electroencephalogram abnormal, encephalitis, eosinophil percentage decreased, gait disturbance. MEMANTINE dosage: unknown. During the same period patient was treated with CAPTOPRIL. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5786691-1
Consumer or non-health professional from FRANCE reported MEMANTINE problem on June 11, 2008. Male patient, 87 years of age, weighting 121.3 lb, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bedridden, blood albumin decreased, gait disturbance, malnutrition, pulmonary embolism. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with STABLON, EQUANIL, BRICANYL, PULMICORT, IMOVANE. Patient died on 03/24/2008.
Memantine Side Effects Report #5788715-4
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on June 11, 2008. Female patient, 81 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood creatinine increased, pancreatic pseudocyst, pancreatitis, peritoneal effusion, pleural effusion. MEMANTINE dosage: 5 MG BID PO. During the same period patient was treated with LYPANTHYL, DEPAMIDE, ARICEPT, ATACAND, VASTAREL, ACTONEL. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5798718-1
Consumer or non-health professional from FRANCE reported MEMANTINE problem on June 17, 2008. Female patient, 94 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: hepatic failure, serum ferritin increased. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with KARDEGIC, ZESTORETIC. Patient was hospitalized. Patient died on 11/10/2007.
Memantine Side Effects Report #5798793-4
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on June 12, 2008. Male patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with MIRTAZAPINE. Patient recovered.
Memantine Side Effects Report #5732541-9
Consumer or non-health professional from FRANCE reported MEMANTINE problem on Apr 21, 2008. Female patient, 85 years of age, was diagnosed with aggression, agitation and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, agitation, crepitations, electrocardiogram st segment depression, heart rate increased, hypertensive crisis, myocardial infarction, sinus tachycardia. MEMANTINE dosage: 5 MG BID PO. During the same period patient was treated with TIAPRIDAL, RAMIPRIL, LASIX, RISPERDAL, OXAZEPAM, AUGMENTIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5736300-2
MEMANTINE problem was reported by a Consumer or non-health professional from FRANCE on Apr 22, 2008. Female patient, 82 years of age, was diagnosed with dementia alzheimer's type, hypertension, urinary incontinence and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood glucose increased, blood urea increased, bradycardia, loss of consciousness, malaise, orthostatic hypotension. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with MODUCREN, ARICEPT, TANAKAN, LANSOPRAZOLE, DITROPAN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5736904-7
Health Professional from FRANCE reported MEMANTINE problem on Apr 24, 2008. Female patient, 86 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: aggression, disorientation. MEMANTINE dosage: 5 MG QD PO. During the same period patient was treated with ARICEPT, STABLON, FORLAX, SOTALOL, DIOSMINE. Patient recovered.
Memantine Side Effects Report #5739577-2
MEMANTINE problem was reported by a Consumer or non-health professional from ITALY on Apr 26, 2008. Female patient, 92 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: hepatitis cholestatic. MEMANTINE dosage: 5 MG QD PO. During the same period patient was treated with DIGOXIN, LISINOPRIL, TIAPRIDE, ALPRAZOLAM, PROMAZINE HYDROCHLORIDE. Patient recovered.
Memantine Side Effects Report #5739701-1
Consumer or non-health professional from GERMANY reported MEMANTINE problem on Apr 28, 2008. Female patient, child 4 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, c-reactive protein increased, disturbance in attention, electroencephalogram abnormal, eosinophil percentage decreased, gait disturbance, lymphocyte percentage decreased. MEMANTINE dosage: unknown. During the same period patient was treated with CAPTOPRIL. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5742401-5
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on Apr 29, 2008. Female patient was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: electroencephalogram abnormal, epilepsy, no therapeutic response, tremor. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with ATHYMIL, RISPERDAL. Patient recovered.
Memantine Side Effects Report #5748685-1
Consumer or non-health professional from GERMANY reported MEMANTINE problem on Mar 06, 2008. Female patient, 75 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholecystitis infective, pancreatitis, sepsis syndrome. MEMANTINE dosage: unknown. During the same period patient was treated with DAPSONE, VITAMIN, FOLIC ACID, VITAMIN E, VITAMIN B12ECTION, CLARITIN, CALATRATE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5748899-0
MEMANTINE problem was reported by a Consumer or non-health professional from JAPAN on May 09, 2008. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: abasia, abdominal pain, alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, b-cell lymphoma stage iv, blood calcium decreased, blood chloride decreased. MEMANTINE dosage: 20 MG QD;PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 03/29/2006.
Memantine Side Effects Report #5758171-0
Consumer or non-health professional from GERMANY reported MEMANTINE problem on May 14, 2008. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: thrombophlebitis superficial. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with REMINYL. Patient recovered.
Memantine Side Effects Report #5758173-4
MEMANTINE problem was reported by a Consumer or non-health professional from GERMANY on May 14, 2008. Male patient, 74 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: amnesia, coordination abnormal, disorientation, dizziness, insomnia, syncope. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DIANBEN, HUMULINE NPH, ACETYLSALICYLIC ACID SRT, ANAGASTRA, NEURONTIN, ATORVASTATIN CALCIUM, EXELON. Patient recovered.
Memantine Side Effects Report #5692718-8
Health Professional from UNITED STATES reported MEMANTINE problem on Mar 27, 2008. Female patient, 82 years of age, weighting 98.00 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: amnesia, bedridden, blood pressure diastolic decreased, body temperature decreased, cerebrovascular accident, hypothyroidism, restlessness, skin laceration. MEMANTINE dosage: 28 MG QD. During the same period patient was treated with DONEPEZIL, NORVASC, FOLIC ACID. Patient was hospitalized. Patient died on 03/04/2006.
Memantine Side Effects Report #5692881-9
MEMANTINE problem was reported by a Consumer or non-health professional from FRANCE on Mar 18, 2008. Female patient, 94 years of age, was diagnosed with dementia alzheimer's